Fig. 3From: Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancerThe nomogram of the Cox proportional hazards model with Ki67 in our cohort shows that CDK9 outperforms Ki-67 in predicting recurrence-free survival. RFS – recurrence-free survivalBack to article page